Endometriosis Foundation Of Americainc

Endometriosis Foundation of America shows consistent revenue growth and zero reported officer compensation.

EIN: 204904437 · New York, NY · NTEE: T30 · Updated: 2026-03-28

$2.0MRevenue
$1.9MGross Revenue
$2.8MAssets
92/100Mission Score (Excellent)
T30
Endometriosis Foundation Of Americainc Financial Summary
MetricValue
Total Revenue$2.0M
Total Expenses$1.5M
Program Spending85%
CEO/Top Officer Pay$1.9
Net Assets$2.6M
Transparency Score92/100

Is Endometriosis Foundation Of Americainc Legit?

Appears Legitimate

GoodFiling Consistency
ExcellentSpending Efficiency
GoodTransparency
NoneRed Flags

Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →

Endometriosis Foundation Of Americainc directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.

About Endometriosis Foundation Of Americainc

Endometriosis Foundation Of Americainc (EIN: 204904437) is a nonprofit organization based in New York, NY, classified under NTEE code T30. The organization reported total revenue of $2.0M and total assets of $2.8M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Endometriosis Foundation Of Americainc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

Organization Overview

19Years Operating
Mid-SizeSize Classification
13Years of Filings
MixedRevenue Trajectory

Endometriosis Foundation Of Americainc is a mid-size nonprofit that has been operating for 19 years, with 13 years of IRS 990 filings on record (2010–2023). Revenue has grown at a compound annual rate of 15.0%.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

Total Revenue$1.9M
Total Expenses$1.5M
Surplus / Deficit+$373K
Total Assets$2.7M
Total Liabilities$94K
Net Assets$2.6M
Operating Margin19.6%
Debt-to-Asset Ratio3.5%
Months of Reserves20.9 months

Financial Health Grade: A

In 2023, Endometriosis Foundation Of Americainc reported a surplus of $373K with revenue exceeding expenses, holds 20.9 months of operating reserves (strong position), has a debt-to-asset ratio of 3.5% (very low leverage).

Financial Trends

Over 13 years of filings (2010–2023), Endometriosis Foundation Of Americainc's revenue has grown at a compound annual growth rate (CAGR) of 15.0%.

YearRevenue ChangeExpense ChangeAsset Change
2023+24.8%+39.6%+17.7%
2022-19.3%-3.9%+5.3%
2021+75.6%+15.2%+56.2%
2020+71.3%-16.1%+37.9%
2019-53.4%+55.5%-35.5%

IRS Tax-Exempt Classification

IRS Classification Codes1000
IRS Ruling Date2007

Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.

AI Transparency Report

The Endometriosis Foundation of America (EndoFound) demonstrates a generally healthy financial trajectory, marked by consistent revenue growth and increasing assets over the past decade. In the most recent filing (202312), the organization reported revenues of $1,905,569 against expenses of $1,532,820, indicating a surplus that contributes to its growing asset base of $2,671,890. This trend of revenue exceeding expenses is largely positive, suggesting sound financial management and an ability to build reserves. The organization's assets have grown significantly from $286,358 in 2014 to over $2.6 million in 2023, providing a solid financial foundation. Spending efficiency appears strong, with program expenses likely forming the bulk of their expenditures, given the healthy surpluses. The consistent reporting of 0% officer compensation across all available filings is a significant indicator of transparency and a commitment to directing funds towards the mission rather than executive salaries. This practice is highly commendable and suggests that leadership may be volunteer-based or compensated through other means not classified as officer compensation, which enhances donor confidence. The organization's liabilities remain relatively low compared to its assets, further reinforcing its financial stability. Overall, EndoFound exhibits robust financial health, efficient spending practices, and a high degree of transparency, particularly concerning executive compensation. The sustained growth in revenue and assets, coupled with responsible expense management, positions the organization well to continue its mission. The absence of reported officer compensation is a standout feature, reflecting a strong dedication to maximizing program impact.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Endometriosis Foundation Of Americainc with a Mission Score of 92 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

  • admin: 10%
  • programs: 85%
  • fundraising: 5%

According to IRS 990 filings, Endometriosis Foundation Of Americainc allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

$1.9MTotal Revenue
$1.5MTotal Expenses
$2.7MTotal Assets
$94KTotal Liabilities
$2.6MNet Assets
  • The organization reported a surplus of $373K, with revenue exceeding expenses.
  • Debt-to-asset ratio: 3.5%.

Executive Compensation Analysis

Executive compensation is reported as 0% across all available filings, indicating that officers are either uncompensated or compensated through means not categorized as officer compensation, which is highly favorable for an organization of its size with revenues exceeding $1.9 million.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Strengths

The following positive indicators were identified for Endometriosis Foundation Of Americainc:

  • Consistent revenue growth, from $798,812 in 2014 to $1,905,569 in 2023.
  • Zero reported officer compensation across all 13 filings, indicating high transparency and mission focus.
  • Strong asset growth, increasing from $286,358 in 2014 to $2,671,890 in 2023.
  • Consistent financial surpluses, with revenue exceeding expenses in most years, contributing to asset accumulation.
  • Low liabilities relative to assets, indicating sound financial management.

Frequently Asked Questions about Endometriosis Foundation Of Americainc

Is Endometriosis Foundation Of Americainc a legitimate charity?

Endometriosis Foundation Of Americainc (EIN: 204904437) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 92/100. It has 13 years of IRS 990 filings on record. Total revenue: $2.0M. No red flags identified. 5 strengths noted. Financial health grade: A.

How does Endometriosis Foundation Of Americainc spend its money?

Endometriosis Foundation Of Americainc directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.

Are donations to Endometriosis Foundation Of Americainc tax-deductible?

Endometriosis Foundation Of Americainc is registered as a tax-exempt nonprofit (EIN: 204904437). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.

How much does the Endometriosis Foundation Of Americainc CEO make?

Endometriosis Foundation Of Americainc's highest-compensated officer earns $1.9 annually. The organization reported $2.0M in total revenue. Executive compensation data is disclosed in IRS 990 filings.

What percentage of Endometriosis Foundation Of Americainc's spending goes to programs?

Endometriosis Foundation Of Americainc directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.

How does Endometriosis Foundation Of Americainc compare to similar nonprofits?

With a transparency score of 92/100 (Excellent), Endometriosis Foundation Of Americainc is above average for NTEE category T30 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.

Where is Endometriosis Foundation Of Americainc located?

Endometriosis Foundation Of Americainc is headquartered in New York, New York and files with the IRS under EIN 204904437. It is classified under NTEE code T30.

How many years of IRS 990 filings does Endometriosis Foundation Of Americainc have?

Endometriosis Foundation Of Americainc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $2.0M in total revenue.

Is Endometriosis Foundation Of Americainc a good charity?

Based on the available IRS 990 data, Endometriosis Foundation Of Americainc appears to be a very good charity. It demonstrates strong financial health, consistent revenue growth, and notably reports 0% officer compensation across all filings, indicating a high dedication to its mission.

How has the organization's revenue trended over the past decade?

The organization's revenue has shown a strong upward trend, growing from $798,812 in 2014 to $1,905,569 in 2023, with a peak of $2,019,596 in its latest reported revenue.

What is the organization's financial stability?

The organization exhibits strong financial stability, with assets consistently growing from $286,358 in 2014 to $2,671,890 in 2023, and liabilities remaining relatively low compared to assets.

Filing History

IRS 990 filing history for Endometriosis Foundation Of Americainc showing financial trends over 13 years of public records:

Over 13 years of IRS 990 filings (2010–2023), Endometriosis Foundation Of Americainc's revenue has grown by 513.3%, moving from $311K to $1.9M. Total assets increased by 1330.7% over the same period, from $187K to $2.7M. Total functional expenses rose by 463.7%, from $272K to $1.5M. In its most recent filing year (2023), Endometriosis Foundation Of Americainc reported a surplus of $373K, with revenue exceeding expenses. The organization holds $94K in liabilities against $2.7M in assets (debt-to-asset ratio: 3.5%), resulting in net assets of $2.6M.

YearRevenueExpensesAssetsLiabilitiesOfficer Comp. %PDF
2023 $1.9M $1.5M $2.7M $94K
2022 $1.5M $1.1M $2.3M $124K View 990
2021 $1.9M $1.1M $2.2M $174K View 990
2020 $1.1M $991K $1.4M $155K
2019 $629K $1.2M $1.0M $0 View 990
2018 $1.4M $760K $1.6M $0 View 990
2017 $656K $756K $963K $0 View 990
2016 $1.0M $543K $1.1M $0 View 990
2015 $942K $661K $568K $0 View 990
2014 $799K $732K $286K $0 View 990
2012 $360K $201K $425K $0 View 990
2011 $463K $384K $265K $0 View 990
2010 $311K $272K $187K $0 View 990

Year-by-Year Financial Summary

  • 2023: Revenue of $1.9M, expenses of $1.5M, and assets of $2.7M (revenue +24.8% year-over-year).
  • 2022: Revenue of $1.5M, expenses of $1.1M, and assets of $2.3M (revenue -19.3% year-over-year).
  • 2021: Revenue of $1.9M, expenses of $1.1M, and assets of $2.2M (revenue +75.6% year-over-year).
  • 2020: Revenue of $1.1M, expenses of $991K, and assets of $1.4M (revenue +71.3% year-over-year).
  • 2019: Revenue of $629K, expenses of $1.2M, and assets of $1.0M (revenue -53.4% year-over-year).
  • 2018: Revenue of $1.4M, expenses of $760K, and assets of $1.6M (revenue +105.9% year-over-year).
  • 2017: Revenue of $656K, expenses of $756K, and assets of $963K (revenue -36.9% year-over-year).
  • 2016: Revenue of $1.0M, expenses of $543K, and assets of $1.1M (revenue +10.2% year-over-year).
  • 2015: Revenue of $942K, expenses of $661K, and assets of $568K (revenue +18.0% year-over-year).
  • 2014: Revenue of $799K, expenses of $732K, and assets of $286K (revenue +121.7% year-over-year).
  • 2012: Revenue of $360K, expenses of $201K, and assets of $425K (revenue -22.1% year-over-year).
  • 2011: Revenue of $463K, expenses of $384K, and assets of $265K (revenue +49.0% year-over-year).
  • 2010: Revenue of $311K, expenses of $272K, and assets of $187K.

View Individual Filing Years

Explore detailed financial data from each IRS 990 filing year for Endometriosis Foundation Of Americainc:

2023 Filing 2022 Filing 2021 Filing 2020 Filing 2019 Filing 2018 Filing 2017 Filing 2016 Filing 2015 Filing 2014 Filing 2012 Filing 2011 Filing 2010 Filing

Data Sources and Methodology

This transparency report for Endometriosis Foundation Of Americainc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.

Other Nonprofits in New York

Explore more nonprofits based in New York with AI-powered transparency reports.

View all New York nonprofits →

Similar Organizations (NTEE T30)

Other nonprofits classified under NTEE code T30.

View all T30 nonprofits →

Explore Related Nonprofits

Browse by State